Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-02-24
1986-10-21
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544138, 544238, 544333, 544367, 546277, 548131, 548132, 548133, C07D27106, A01K 3141
Patent
active
046186174
ABSTRACT:
This disclosure describes novel 5-substituted 1,2,4-oxadiazoles useful as pharmaceuticals such as anti-inflammatory and analgesic agents.
REFERENCES:
patent: 3697530 (1972-10-01), Imai et al.
patent: 3887573 (1975-06-01), Breuer et al.
patent: 3910942 (1975-10-01), Narayanan
patent: 4069332 (1978-01-01), Wright
Korbonits, J. Chem. Res. Synop. (2), 64 (1979), Abstract.
Chem. Abstracts, vol. 95, 1981, p. 673, 95:150674y.
Hynes, J. Med. Chem., 15, 1198 (1972).
Rieber, J. Heterocyclic Chem., 18, 1 (1981).
Gerstl Robert
Sumitomo Chemical Company Limited
LandOfFree
Novel 5-substituted 1,2,4,-oxadiazole derivatives and preparatio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel 5-substituted 1,2,4,-oxadiazole derivatives and preparatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel 5-substituted 1,2,4,-oxadiazole derivatives and preparatio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1290070